- $842.12m
- $871.98m
- $645.72m
- 86
- 56
- 22
- 54
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 430 | 418 | 741 | 905 | 646 |
Cost of Revenue | |||||
Gross Profit | 375 | 364 | 662 | 818 | 581 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 436 | 354 | 750 | 807 | 566 |
Operating Profit | -6.32 | 64.4 | -8.39 | 97.2 | 79.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.76 | 64.3 | -9.28 | 74.1 | 70.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -6.35 | 86 | 3.6 | 61.5 | 49.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -6.35 | 86 | 3.6 | 61.5 | 49.1 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -10.1 | 63 | 1.95 | 61.5 | 49.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.096 | 0.602 | 0.016 | 0.507 | 0.464 |
Dividends per Share |